×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Patient History

  • Female, 72 years 
  • Risk factors:
    • Hypercholesterolaemia
    • Hypertension
    • Heavy smoker
  • Main comorbidities:
    • CAD
    • Previous surgical treatment of left iliac and left groin arteries
  • Clinical presentation:
    • Claudication Left calf thigh (Rutherford clinical category 2-3)
    • Moderately calcified distal common femoral artery restenosis, 
    • Repeat surgical treatment left external iliac and left CFA (Iliofemoral bypass graft infection, repeat bypass surgery, allograft implantation)
    • Absolute walking capacity 300 m
    • ABI: 0.75

Protocol

  • Procedure time: 45 min
  • Exposure time: 8 min
  • Exposure: 819 mGy
  • Contrast volume: 80 ml
Shooting date : 2018-10-09
Last update : 2021-06-09
3 comments
Join the Discussion
  • K R. What about doing plasty of the graft lesion without atherectomy in this case.
    Because doing atherectomy of graft disease carries risk of rupture . What is your suggestion

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Antoine T. Just learning

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Antoine T. Symptoms

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        Suggestions

        Wednesday, October 10th 2018 from 12pm to 01:30pm (GMT+2)
        Honolulu : Wednesday, October 10th 2018 from 12am to 01:30am (GMT-10)
        San Francisco : Wednesday, October 10th 2018 from 03am to 04:30am (GMT-7)
        New York : Wednesday, October 10th 2018 from 06am to 07:30am (GMT-4)
        Buenos Aires : Wednesday, October 10th 2018 from 07am to 08:30am (GMT-3)
        Reykjavik : Wednesday, October 10th 2018 from 10am to 11:30am (GMT)
        London / Dublin : Wednesday, October 10th 2018 from 11am to 12:30pm (GMT+1)
        Paris / Berlin : Wednesday, October 10th 2018 from 12pm to 01:30pm (GMT+2)
        Istanbul : Wednesday, October 10th 2018 from 01pm to 02:30pm (GMT+3)
        Moscou / Dubaï : Wednesday, October 10th 2018 from 02pm to 03:30pm (GMT+4)
        Bangkok : Wednesday, October 10th 2018 from 05pm to 06:30pm (GMT+7)
        Shanghai : Wednesday, October 10th 2018 from 06pm to 07:30pm (GMT+8)
        Tokyo : Wednesday, October 10th 2018 from 07pm to 08:30pm (GMT+9)
        Sydney : Wednesday, October 10th 2018 from 09pm to 10:30pm (GMT+11)
        Wellington : Wednesday, October 10th 2018 from 11pm to 12:30am (GMT+13)

        Calcium, Dissections, No Stent Zones: How leading centers are fighting the last challenges in the SF...

        Live from University Hospital Leipzig

        Share
        Friday, February 23rd 2024 from 11am to 12:30pm (GMT+2)
        Honolulu : Thursday, February 22nd 2024 from 11pm to 12:30am (GMT-10)
        San Francisco : Friday, February 23rd 2024 from 01am to 02:30am (GMT-8)
        New York : Friday, February 23rd 2024 from 04am to 05:30am (GMT-5)
        Buenos Aires : Friday, February 23rd 2024 from 06am to 07:30am (GMT-3)
        London / Dublin : Friday, February 23rd 2024 from 09am to 10:30am (GMT)
        Paris / Berlin : Friday, February 23rd 2024 from 10am to 11:30am (GMT+1)
        Istanbul : Friday, February 23rd 2024 from 11am to 12:30pm (GMT+2)
        Moscou / Dubaï : Friday, February 23rd 2024 from 01pm to 02:30pm (GMT+4)
        Bangkok : Friday, February 23rd 2024 from 04pm to 05:30pm (GMT+7)
        Shanghai : Friday, February 23rd 2024 from 05pm to 06:30pm (GMT+8)
        Tokyo : Friday, February 23rd 2024 from 06pm to 07:30pm (GMT+9)
        Sydney : Friday, February 23rd 2024 from 07pm to 08:30pm (GMT+10)
        Wellington : Friday, February 23rd 2024 from 09pm to 10:30pm (GMT+12)

        Realizing the PAD Workflow of the Future

        A more efficient and Versatile Approach to Complex Lesions

        Share
        Thursday, November 4th 2021 from 05pm to 06:15pm (GMT+2)
        Honolulu : Thursday, November 4th 2021 from 05am to 06:15am (GMT-10)
        San Francisco : Thursday, November 4th 2021 from 07am to 08:15am (GMT-8)
        New York : Thursday, November 4th 2021 from 10am to 11:15am (GMT-5)
        Buenos Aires : Thursday, November 4th 2021 from 12pm to 01:15pm (GMT-3)
        London / Dublin : Thursday, November 4th 2021 from 03pm to 04:15pm (GMT)
        Paris / Berlin : Thursday, November 4th 2021 from 04pm to 05:15pm (GMT+1)
        Istanbul : Thursday, November 4th 2021 from 05pm to 06:15pm (GMT+2)
        Moscou / Dubaï : Thursday, November 4th 2021 from 07pm to 08:15pm (GMT+4)
        Bangkok : Thursday, November 4th 2021 from 10pm to 11:15pm (GMT+7)
        Shanghai : Thursday, November 4th 2021 from 11pm to 12:15am (GMT+8)
        Tokyo : Friday, November 5th 2021 from 12am to 01:15am (GMT+9)
        Sydney : Friday, November 5th 2021 from 01am to 02:15am (GMT+10)
        Wellington : Friday, November 5th 2021 from 03am to 04:15am (GMT+12)

        Challenges of fempop interventions – Crossing of complex lesions and preventing restenosis

        Swirling Flow: a replacement for anti-proliferative coating?

        Share
        Scroll Up